These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27594108)

  • 1. Recognition of community-based pharmacist practitioners: Essential health care providers.
    Bennett M; Goode JV
    J Am Pharm Assoc (2003); 2016; 56(5):580-3. PubMed ID: 27594108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pharmacist care provision in value-based care settings: How are we measuring value-added services?
    Cowart K; Olson K
    J Am Pharm Assoc (2003); 2019; 59(1):125-128. PubMed ID: 30573372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spirometry: tool for pharmacy practitioners to expand direct patient care services.
    Cawley MJ; Moon J; Reinhold J; Willey VJ; Warning Ii WJ
    J Am Pharm Assoc (2003); 2013; 53(3):307-15. PubMed ID: 23699680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for community-based medication management services in value-based health plans.
    Smith MA; Spiggle S; McConnell B
    Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The paradox of pharmacy: A profession's house divided.
    Brown D
    J Am Pharm Assoc (2003); 2012; 52(6):e139-43. PubMed ID: 23143300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists as mid-level practitioners/providers.
    Ross LA
    Ann Pharmacother; 2011 Jun; 45(6):810-2. PubMed ID: 21666080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The I-Tribe Community Pharmacy Practice Model: professional pharmacy unshackled.
    Alston GL; Waitzman JA
    J Am Pharm Assoc (2003); 2013; 53(2):163-71. PubMed ID: 23571624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a vision and strategic action plan for future community-based residency training.
    Skelton JB; Owen JA
    J Am Pharm Assoc (2003); 2016; 56(5):584-589.e1. PubMed ID: 27594109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework.
    Kibicho J; Owczarzak J
    AIDS Patient Care STDS; 2012 Jan; 26(1):20-8. PubMed ID: 22149903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating pharmacists into diverse diabetes care teams: implementation tactics from Project IMPACT: Diabetes.
    Watson LL; Bluml BM
    J Am Pharm Assoc (2003); 2014; 54(5):538-41. PubMed ID: 25216884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Iowa new practice model: Advancing technician roles to increase pharmacists' time to provide patient care services.
    Andreski M; Myers M; Gainer K; Pudlo A
    J Am Pharm Assoc (2003); 2018; 58(3):268-274.e1. PubMed ID: 29606624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the Role of Community Pharmacists in Managing the Health of Populations: Barriers, Facilitators, and Policy Recommendations.
    Newman TV; Hernandez I; Keyser D; San-Juan-Rodriguez A; Swart ECS; Shrank WH; Parekh N
    J Manag Care Spec Pharm; 2019 Sep; 25(9):995-1000. PubMed ID: 31456493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric asthma medication therapy management through community pharmacy and primary care collaboration.
    Bradley CL; Luder HR; Beck AF; Bowen R; Heaton PC; Kahn RS; Mansour M; Obszarski S; Frede SM
    J Am Pharm Assoc (2003); 2016; 56(4):455-60. PubMed ID: 27245855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of pharmacist-provided point of care testing.
    Kuhn CH
    J Am Pharm Assoc (2003); 2015; 55(6):572-573. PubMed ID: 26547594
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing care team perspectives on integration of a community pharmacist into an ambulatory care practice.
    Riggins SR; Abode AM; Holland CR; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S122-S128.e1. PubMed ID: 31231003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.
    Franco-Trigo L; Hossain LN; Durks D; Fam D; Inglis SC; Benrimoj SI; Sabater-Hernández D
    Res Social Adm Pharm; 2017; 13(3):539-552. PubMed ID: 27485770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer willingness to pay for pharmacy services: An updated review of the literature.
    Painter JT; Gressler L; Kathe N; Slabaugh SL; Blumenschein K
    Res Social Adm Pharm; 2018 Dec; 14(12):1091-1105. PubMed ID: 29398405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing pharmacist-led annual wellness visits: Interventions made and patient and physician satisfaction.
    Wilson CG; Park I; Sutherland SE; Ray L
    J Am Pharm Assoc (2003); 2015; 55(4):449-54. PubMed ID: 26161489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis.
    Gregório J; Cavaco AM; Lapão LV
    Res Social Adm Pharm; 2017; 13(1):133-147. PubMed ID: 26997136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.